ABBV
ABBV
NYSE · Biotechnology

Abbvie Inc

S&P 500 Mega-Cap Stocks Blue Chip Stocks Biotech Stocks Healthcare Stocks Best Dividend Stocks Highest Dividend Yield
$234.76
+4.75 (+2.07%)
Analyst Consensus
Strong Buy
40
Analysts
Very High
Coverage
Buy 31 78%
Hold 9 23%
Sell 0 0%
Price Target
Analyst Price Target +9.7% upside
Low Target $173.19
Average Target $257.58
High Target $337.66
Current Price $234.76
Current
$234.76
Target
$257.58
$173.19 $257.58 avg $337.66
Scenario Analysis
Bear Case
$173.19
-26.2%
Low target
Base Case
$257.58
+9.7%
Avg target
Bull Case
$337.66
+43.8%
High target
Risk/Reward
1.7x
Balanced
Price in Context
52-Week High
$244.81
-4.1% from high
52-Week Low
$181.73
+29.2% from low
50-Day SMA
$223.82
+4.9% vs SMA
200-Day SMA
$211.12
+11.2% vs SMA
RSI (14)
54.5
Neutral
Target vs 52W High
$257.58
+5.2% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 78% $257.58 +9.7%
AMGN
Amgen Inc
 Hold 44 50% $190.87 -45.0%
GILD
Gilead Sciences Inc
 Strong Buy 39 82% $362.68 +190.0%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 40 83% $438.34 -6.4%
REGN
Regeneron Pharmaceuticals
 Buy 38 71% $76.80 -87.6%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 37 76% $102.31 -64.5%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -32.7%
NTRA
Natera Inc
 Strong Buy 27 89% $142.91 -39.1%